For Life Science companies
Patient-centric care should fully capitalise upon our understanding of drugs, diagnostics, precision medicine, remote monitoring and digital health, combining these with a real-time feedback process to optimise patient regimens and outcomes. The ability to capture real world patient data across a care pathway, combined with a closed-loop management system, enables precision care for each patient whilst supporting outcomes-based reimbursement at a population scale.
We have a pipeline of pathway interventions in development that integrate Digital + Drug + Device for the treatment of some of the biggest challenges facing 21st century health systems - sleep disorders, hypertension, chronic pain, Depression and diabetes.
Our digital therapeutics platform provides a new way for companies to capture long-term value and co-create novel IP around existing drugs. CLM is seeking additional co-development partnerships with the BioPharmaceutical industry.